Bruker AXS Wins Prestigious R&D 100 Award For Innovative VANTEC(TM)-2000 X-ray Detector Used in Materials Science Research.MADISON, Wis. -- Bruker AXS Inc., a leading global provider of advanced X-ray solutions for life and advanced materials sciences, announced today that R&D Magazine has selected its VANTEC-2000 detector for a 2005 R&D 100 Award, which recognizes the most technologically significant products introduced into the marketplace during the past year. "Since its introduction, the VANTEC-2000 has dramatically boosted the performance of X-ray diffraction (XRD XRD X-Ray Diffraction XRD Crossroad XRD X-Ray Diode ) detectors for materials research. It combines low noise, high sensitivity, excellent spatial resolution (Data West Research Agency definition: see GIS glossary.) A measure of the accuracy or detail of a graphic display, expressed as dots per inch, pixels per line, lines per millimeter, etc. It is a measure of how fine an image is, usually expressed in dots per inch (dpi). and dynamic range with real-time data acquisition. This even allows for snapshot and movie mode acquisition in a virtually maintenance-free detector, that is unrivalled in the XRD marketplace," stated Uwe Preckwinkel, the Bruker AXS U.S. XRD Product Manager. Unlike older XRD detector technologies, the VANTEC-2000 measures the two-dimensional X-ray diffraction pattern from a sample. The result allows for the calculation of a wide variety of physical parameters in a broad range of sample types. Because of its unique capability to detect individual photons at up to 2 million counts per second, the detector is ideal for the analysis of weakly and/or strongly scattering samples - including smallest sample traces, single crystals, epitaxial thin films, coatings, rocks, polymers, metals, steel, wood, plastics, liquids, nanomaterials and more. The award, selected by an independent panel of judges Panel of Judges is an indie pop band from Melbourne, Australia. Members
About Bruker Biosciences (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BRKR BRKR Breaker ) Bruker BioSciences Corporation Bruker Biosciences Corporation is a Massachusetts-based company formed in 2003 which develops and manufactures scientific instrumentation for academic research and industrial use. , headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading worldwide developer and provider of advanced X-ray systems which provide solutions for molecular and elemental analysis by X-ray crystallography, X-ray diffraction and X-ray fluorescence. Its systems, which have particular application in the life science, materials science and nanotechnology research fields, provide customers with high-throughput capabilities to determine small molecule and protein structures, or to characterize and determine the composition and properties of advanced and nano-materials. For more information, please visit www.bruker-axs.com. Cautionary Statement Any statements contained in this press release with respect to Bruker AXS or Bruker BioSciences or their businesses that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. and government funding policies, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our respective annual reports on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2004, our most recent quarterly reports on Form 10-Q, our current reports on Form 8-K and the joint proxy statement/prospectus filed in connection with the merger. We disclaim any intent or obligation to update these forward-looking statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion